Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH Akonni Biosystems, a molecular diagnostics company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Wellness Read more . The award will enable Akonni to mix PCR with its existing TruArray gel-drop microarray in a single chamber, closed-amplicon system, and field test drive it for the detection of influenzas A and B and their antigenic subtypes, including antiviral resistant types.

Akeso Medical Imaging closes first financing round to build up imaging device for rheumatoid arthritis disease activity monitoring and control Akeso Medical Imaging BV, a spin-off from Philips Study, announces today the closure of its first financing round led by Thuja Capital Healthcare Seed Fund with extra financing from the Brabant Spin-Off Fund and Point-One Creativity Fund. The funds will be utilized to further develop the imaging software program and system, its scientific validation and for obtaining regulatory approval in European countries.